title: Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection.
abstract: Herpes simplex virus type 1 (HSV-1) infection of the cornea induces vascular endothelial growth factor A (VEGF-A)-dependent lymphangiogenesis that continues to develop well beyond the resolution of infection. Inflammatory leukocytes infiltrate the cornea and have been implicated to be essential for corneal neovascularization, an important clinically relevant manifestation of stromal keratitis. Here we report that cornea infiltrating leukocytes including neutrophils and T cells do not have a significant role in corneal neovascularization past virus clearance. Antibody-mediated depletion of these cells did not impact lymphatic or blood vessel genesis. Multiple pro-angiogenic factors including IL-6, angiopoietin-2, hepatocyte growth factor, fibroblast growth factor-2 (FGF-2), VEGF-A, and matrix metalloproteinase-9 were expressed within the cornea following virus clearance. A single bolus of dexamethasone at day 10 post infection (pi) resulted in suppression of blood vessel genesis and regression of lymphatic vessels at day 21 pi compared to control-treated mice. Whereas IL-6 neutralization had a modest impact on hemangiogenesis (days 14-21 pi) and lymphangiogenesis (day 21 pi) in a time-dependent fashion, neutralization of FGF-2 had a more pronounced effect on the suppression of neovascularization (blood and lymphatic vessels) in a time-dependent, leukocyte-independent manner. Furthermore, FGF-2 neutralization suppressed the expression of all pro-angiogenic factors measured and preserved visual acuity.
authors.affiliation: Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
authors.forename: H R
authors.initials: HR
authors.lastname: Gurung
authors.affiliation: Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: Carr
authors.affiliation: Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
authors.forename: K
authors.initials: K
authors.lastname: Bryant
authors.affiliation: Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Chucair-Elliott
authors.affiliation: Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.|Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
authors.forename: D Jj
authors.initials: DJ
authors.lastname: Carr
mesh_terms: D000818:Animals; D003315:Cornea / Q000098:blood supply* / Q000821:virology; D016510:Corneal Neovascularization; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D006561:Herpes Simplex / Q000188:drug therapy / Q000276:immunology*; D018259:Herpesvirus 1, Human / Q000502:physiology*; D015850:Interleukin-6 / Q000378:metabolism; D016849:Keratitis, Herpetic / Q000188:drug therapy / Q000276:immunology*; D042583:Lymphangiogenesis; D020780:Matrix Metalloproteinase 9 / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009504:Neutrophils / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014792:Visual Acuity
chemical_list: D015850:Interleukin-6; D016222:Fibroblast Growth Factor 2; D003907:Dexamethasone; D020780:Matrix Metalloproteinase 9; C501830:Mmp9 protein, mouse